Prime Capital Investment Advisors LLC bought a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund bought 979 shares of the semiconductor company’s stock, valued at approximately $504,000.
Other hedge funds have also added to or reduced their stakes in the company. Cibc World Market Inc. lifted its stake in shares of Synopsys by 58.8% in the 1st quarter. Cibc World Market Inc. now owns 11,893 shares of the semiconductor company’s stock worth $3,964,000 after purchasing an additional 4,402 shares during the period. Prudential PLC purchased a new stake in Synopsys during the first quarter valued at approximately $993,000. Sequoia Financial Advisors LLC bought a new position in Synopsys in the first quarter worth approximately $240,000. Covestor Ltd boosted its stake in shares of Synopsys by 18.9% during the 1st quarter. Covestor Ltd now owns 271 shares of the semiconductor company’s stock worth $90,000 after acquiring an additional 43 shares during the last quarter. Finally, Mather Group LLC. grew its position in shares of Synopsys by 64.4% during the 1st quarter. Mather Group LLC. now owns 1,680 shares of the semiconductor company’s stock valued at $560,000 after acquiring an additional 658 shares during the period. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys Price Performance
SNPS stock opened at $561.23 on Thursday. Synopsys, Inc. has a 1-year low of $360.36 and a 1-year high of $629.38. The company has a market capitalization of $85.59 billion, a price-to-earnings ratio of 61.81, a PEG ratio of 3.37 and a beta of 1.06. The business has a 50 day simple moving average of $569.29 and a two-hundred day simple moving average of $530.21.
Wall Street Analysts Forecast Growth
SNPS has been the topic of a number of recent research reports. StockNews.com raised Synopsys from a “hold” rating to a “buy” rating in a report on Monday, March 18th. Piper Sandler initiated coverage on Synopsys in a research note on Thursday, April 4th. They issued an “overweight” rating and a $665.00 price objective on the stock. Wells Fargo & Company boosted their price objective on Synopsys from $620.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, December 13th. Needham & Company LLC reiterated a “buy” rating and set a $660.00 price objective on shares of Synopsys in a research note on Friday, March 22nd. Finally, Robert W. Baird boosted their price objective on Synopsys from $624.00 to $640.00 and gave the company an “outperform” rating in a research note on Thursday, February 22nd. Eleven investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Synopsys has a consensus rating of “Buy” and an average target price of $601.00.
Get Our Latest Research Report on Synopsys
Insiders Place Their Bets
In other Synopsys news, insider John F. Runkel, Jr. sold 5,319 shares of the company’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $579.37, for a total value of $3,081,669.03. Following the completion of the transaction, the insider now directly owns 20,000 shares in the company, valued at approximately $11,587,400. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, insider John F. Runkel, Jr. sold 5,319 shares of the stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $579.37, for a total transaction of $3,081,669.03. Following the completion of the transaction, the insider now directly owns 20,000 shares in the company, valued at approximately $11,587,400. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Sassine Ghazi sold 10,294 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $577.51, for a total value of $5,944,887.94. Following the transaction, the chief executive officer now owns 61,863 shares of the company’s stock, valued at $35,726,501.13. The disclosure for this sale can be found here. Insiders sold 26,832 shares of company stock worth $15,464,992 in the last three months. 0.66% of the stock is owned by company insiders.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
- Five stocks we like better than Synopsys
- Most active stocks: Dollar volume vs share volume
- Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
- Ride Out The Recession With These Dividend Kings
- WD-40 Company Greases the Wheels of Growth and Profits
- Using the MarketBeat Dividend Yield Calculator
- How to Protect your Portfolio Against a Rising VIX
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.